查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1917789

空间基因组学和转录组学市场——2026-2031年预测

Spatial Genomics and Transcriptomics Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计空间基因组学和转录组学市场将从 2025 年的 732,413,000 美元增长到 2031 年的 1,435,830,000 美元，复合年增长率为 11.87%。

空间基因组学和转录组学市场正迅速扩张，这主要得益于对精准医疗和标靶治疗技术需求的激增。学术机构正将这些工具整合到疾病研究计画中，以更深入地了解细胞异质性。研究人员正利用高解析度空间图谱进一步了解肿瘤微环境和组织结构。生物技术公司正在部署支援单细胞和组织尺度分析的先进定序平台。

空间基因组学和转录组学技术能够视觉化和分析完整组织环境中的基因表现模式，从而保留传统批量定序中遗失的空间组织资讯。这些方法将基因组或转录组分析与形态学数据相结合，揭示细胞相互作用、异质性以及微环境的影响，这对于理解疾病进展和治疗反应至关重要。在肿瘤学、神经病学、免疫学和发育生物学等领域的应用正在推动市场强劲成长，空间资讯有助于提高生物标记的发现、诊断准确性和药物标靶识别。

关键的成长要素在于其在药物发现和开发领域的应用不断扩展，尤其是在癌症和神经系统疾病领域。空间分析有助于理解复杂的病理过程，并为靶向干预提供指南。在人类细胞图谱等计画的支持下，基因组学和转录组学研究的日益增多，正推动着遗传疾病研究领域对空间分析的更大应用。学术机构的广泛应用使得对多种病理进行全面的形态学和分子分析成为可能。单细胞分辨率转录组学的日益普及，以及雷射捕获晶粒等技术的应用，解决了组织异质性问题，并实现了空间数据的保存。

从地区来看，由于对病理学研究的策略性投资、对转录组学研发的重视以及支持高通量定序和空间分辨率进步的强大基础设施，预计北美将占据主要份额。

代表性产品包括 10x Genomics 的 Visium Spatial Gene Expression，它能绘製新鲜冷冻或 FFPE 组织中具有形态学背景的全转录组图谱，为发育、病理和转化研究提供见解；以及 NanoString Technologies 的 GeoMx Digital Spatial Profiler，它能从单个载玻片上进行空间转录组学和蛋白​​质体学分析，它能从单一载玻片上柔软性。

主要企业包括 Natera Inc.、10x Genomics、Dovetail Genomics、Illumina, Inc. 和 S2 Genomics, Inc.。这些公司正在推广整合次世代定序、成像和生物资讯学的平台，以实现高度多重、高解析度的空间分析。

总体而言，市场正在稳步发展，透过保存组织背景，有可能彻底改变人们对疾病的理解，随着慢性疾病变得越来越复杂，调查变得越来越精细，市场有望加速精准诊断和治疗。

本报告的主要优势：

  • 深入分析：获得主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素和未来趋势：探索市场驱动因素和关键趋势，并了解它们将如何影响未来的市场发展。
  • 可操作的建议：利用这些见解，在快速变化的环境中做出策略决策，并发现新的商机和收入来源。
  • 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

研究范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入和预测评估，包括国家/地区
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 按类型分類的空间基因体学和转录组学市场

  • 介绍
  • 空间基因体学
    • 原位杂合反应
    • 次世代定序
    • 其他的
  • 空间转录组学
    • 定序定序
    • 探针基座
    • 成像基地

6. 按应用分類的空间基因组学和转录组学市场

  • 介绍
  • 神经病学
  • 肿瘤学
  • 免疫学
  • 发育生物学
  • 其他的

7. 依最终使用者分類的空间基因组学和转录组学市场

  • 介绍
  • 製药和生物技术公司
  • 学术和研究机构
  • 其他的

8. 各区域空间基因体学及转录组学市场

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • 10x Genomics
  • Illumina, Inc.
  • S2 Genomics, Inc.
  • Bruker Spatial Biology, Inc.
  • Velsera
  • Bio-Techne
  • Akoya Biosciences
  • Standard BioTools
  • Vizgen Inc.
  • Agilent Technologies, Inc.

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615762

Spatial Genomics And Transcriptomics Market is forecasted to rise at a 11.87% CAGR, reaching USD 1435.83 million in 2031 from USD 732.413 million in 2025.

The spatial genomics and transcriptomics market is expanding rapidly, driven by surging demand for technologies enabling precision medicine and targeted therapy development. Academic institutions are integrating these tools into disease research programs for deeper insights into cellular heterogeneity. Researchers are leveraging high-resolution spatial mapping to dissect tumor microenvironments and tissue architecture. Biotech firms are introducing advanced sequencing platforms supporting single-cell and tissue-scale analysis.

Spatial genomics and transcriptomics technologies facilitate the visualization and analysis of gene expression patterns within intact tissue contexts, preserving spatial organization lost in traditional bulk sequencing. These approaches combine genomic or transcriptomic profiling with morphological data, revealing cellular interactions, heterogeneity, and microenvironmental influences critical for understanding disease progression and therapeutic response. The market is growing robustly, fueled by applications in oncology, neurology, immunology, and developmental biology, where spatial context enhances biomarker discovery, diagnostic accuracy, and drug target identification.

Key growth drivers include escalating applications in drug discovery and development, particularly for cancer and neurological disorders, where spatial profiling elucidates complex pathologies and informs targeted interventions. Increasing research in genomics and transcriptomics, supported by initiatives like the Human Cell Atlas, amplifies adoption in academic settings for studying genetically derived diseases. Widespread use in academic facilities provides comprehensive morphological and molecular analyses across diverse conditions. Rising adoption of transcriptomics for single-cell resolution, aided by techniques like laser capture microdissection, addresses tissue heterogeneity and enables archival spatial data preservation.

Geographically, North America is predicted to hold a significant share, attributed to strategic investments in pathology research, emphasis on transcriptomics R&D, and robust infrastructure supporting high-throughput sequencing and spatial resolution advancements.

Prominent products include 10x Genomics' Visium Spatial Gene Expression, which maps whole-transcriptome profiles with morphological context in fresh frozen or FFPE tissues for insights into development, pathology, and translational studies. NanoString Technologies' GeoMx Digital Spatial Profiler enables spatial transcriptomics and proteomics from single slides, offering flexibility from discovery to translational workflows.

Leading companies include Natera Inc., 10x Genomics, Dovetail Genomics, Illumina, Inc., and S2 Genomics, Inc. These entities advance platforms integrating next-generation sequencing, imaging, and bioinformatics for high-plex, high-resolution spatial profiling.

Overall, the market is advancing steadily, positioned to revolutionize disease understanding through preserved tissue context, accelerating precision diagnostics and therapeutics amid rising chronic disease complexity and research intensity.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Spatial Genomics and Transcriptomics Market Segmentation

  • By Type
  • Spatial Genomics
  • In-Situ Hybridization
  • Next-Generation Sequencing
  • Others
  • Spatial Transcriptomics
  • Sequencing-Based
  • Probe-Based
  • Imaging-Based
  • By Application
  • Neurology
  • Oncology
  • Immunology
  • Developmental Biology
  • Others
  • By End-User
  • Pharmaceutical & Biotech Companies
  • Academic & Research Institutes
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Spatial Genomics
    • 5.2.1. In-Situ Hybridization
    • 5.2.2. Next-Generation Sequencing
    • 5.2.3. Others
  • 5.3. Spatial Transcriptomics
    • 5.3.1. Sequencing-Based
    • 5.3.2. Probe-Based
    • 5.3.3. Imaging-Based

6. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Neurology
  • 6.3. Oncology
  • 6.4. Immunology
  • 6.5. Developmental Biology
  • 6.6. Others

7. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Pharmaceutical & Biotech Companies
  • 7.3. Academic & Research Institutes
  • 7.4. Others

8. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. 10x Genomics
  • 10.2. Illumina, Inc.
  • 10.3. S2 Genomics, Inc.
  • 10.4. Bruker Spatial Biology, Inc.
  • 10.5. Velsera
  • 10.6. Bio-Techne
  • 10.7. Akoya Biosciences
  • 10.8. Standard BioTools
  • 10.9. Vizgen Inc.
  • 10.10. Agilent Technologies, Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations